USNA — USANA Health Sciences Balance Sheet
0.000.00%
- $311.92m
- $220.71m
- $925.26m
Annual balance sheet for USANA Health Sciences, fiscal year end - January 3rd, USD millions except per share, conversion factor applied.
2022 December 31st | 2022 January 1st | 2023 December 30th | 2024 December 28th | 2026 January 3rd | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 288 | 240 | 330 | 182 | 158 |
| Net Total Receivables | 10.4 | 9.43 | 8.38 | 9.12 | 10 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 384 | 365 | 418 | 279 | 288 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 118 | 126 | 117 | 116 | 117 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 597 | 578 | 633 | 748 | 743 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 144 | 161 | 119 | 140 | 129 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 162 | 183 | 136 | 216 | 210 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 434 | 395 | 497 | 532 | 533 |
| Total Liabilities & Shareholders' Equity | 597 | 578 | 633 | 748 | 743 |
| Total Common Shares Outstanding |